AllTest® 13-Panel Drug Test Cup

AllTest® 13-Panel Drug Test Cup

AllTest® 13 Panel Drug Test Cup detects AMP500, BAR300, BUP10, BZO300, COC150, MDMA500, MET500, MTD300, OPI300, OXY100, PCP25, THC50, FYL1, CLIA Waived (25/Box)

Standard opiate panels are blind to fentanyl. This CLIA-waived 13 panel drug test cup closes that gap with ultra-sensitive 1 ng/mL fentanyl detection, giving your clinical setting visibility into synthetic opioids without forensic-use-only restrictions.

Rapid urine drug screening for emergency departments

In your emergency department, 5-minute results significantly impact treatment decisions. Doctors need to know if that unconscious patient is on fentanyl before administering certain medications. Standard opiate screens miss fentanyl entirely – this panel catches it.

Pain management clinic monitoring.

For pain management practices, knowing whether patients are using illicit fentanyl alongside or instead of prescribed medications changes everything about treatment planning. This gives you visibility you didn’t have before.

Medication-assisted treatment programs

In MAT clinics, the buprenorphine and methadone panels let you verify compliance while the fentanyl panel reveals whether patients are supplementing with street drugs – critical information for dosing decisions and treatment success.

Occupational health and pre-employment screening.

For workplace testing programs, fentanyl has become too prevalent to ignore. This 13 panel drug test cup gives occupational health the comprehensive screening today’s substance use patterns demand.

Are you still using drug test cups that can’t see fentanyl?

The molecular structure of synthetic fentanyl is fundamentally different from natural opiates like morphine. Traditional immunoassays designed for heroin and prescription opioids are effectively blind to the drug that’s killing more people than any other. In Baltimore-area emergency departments, 83% of patients who had used fentanyl tested negative on standard opiate screens.

This 13 panel drug cup closes that gap. The dedicated fentanyl panel at 1 ng/mL – ten times more sensitive than most competing panels – captures not just pharmaceutical fentanyl but illicit analogs including carfentanil, acetylfentanyl, and fluorofentanyl at lower exposure levels than other tests can detect.

• Ultra-sensitive fentanyl detection at 1 ng/mL. Ten times more sensitive than most competing panels, catching synthetic opioid use that other tests miss.
• CLIA-waived status for point-of-care testing in clinical settings without laboratory certification requirements.
• Comprehensive opioid coverage including oxycodone, buprenorphine, and methadone at sensitivity levels that catch actual use.
• 5-minute results that support real-time clinical decision-making.

What is this product?

AllTest® is a CLIA-waived 13 panel drug test cup that screens urine specimens for 13 substances including fentanyl at an ultra-sensitive 1 ng/mL cutoff, with results in 5 minutes.

Who is it for?

Hospital emergency departments. Pain management clinics. Occupational health programs. Primary care physicians. Psychiatric facilities. Addiction treatment centers. Any clinical setting requiring FDA-cleared, CLIA-waived drug screening with fentanyl detection.

What does it do?

Detects 13 commonly abused substances in a single integrated cup – including fentanyl at an ultra-sensitive 1 ng/mL cutoff. The patient provides a urine sample directly into the cup, and color-coded test strips display results within 5 minutes. Built-in temperature strip verifies sample authenticity.

What are the benefits in your workplace?

Fentanyl detection that traditional opiate panels completely miss. CLIA-waived status for point-of-care use in clinical settings. Buprenorphine and methadone panels for MAT program monitoring. Single-cup convenience eliminates separate fentanyl testing. Volume pricing that stretches your testing budget further.

What problems does it solve?

Patients using fentanyl testing negative on standard opiate screens. Overdose risk going undetected in clinical assessments. Overpaying for the same panel configuration from other suppliers. Supply chain disruptions when your current vendor runs short.

What are your next steps?

Order online now, request organizational pricing from our sales team, or ask for free samples to test against your current brand.